Literature DB >> 17561972

Unexpected cardiotoxicity in haematological bortezomib treated patients.

Orciuolo Enrico, Buda Gabriele, Cecconi Nadia, Galimberti Sara, Versari Daniele, Cervetti Giulia, Salvetti Antonio, Petrini Mario.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17561972     DOI： 10.1111/j.1365-2141.2007.06659.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  80 in total

1.  Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma.

Authors:  Hiroyuki Takamatsu; Takeshi Yamashita; Takeharu Kotani; Aiko Sawazaki; Hirokazu Okumura; Shinji Nakao
Journal:  Int J Hematol       Date:  2010-05-11       Impact factor: 2.490

Review 2.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues.

Authors:  Aldrin V Gomes; Glen W Young; Yueju Wang; Chenggong Zong; Mansoureh Eghbali; Oliver Drews; Haojie Lu; Enrico Stefani; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2008-10-17       Impact factor: 5.911

Review 4.  Build it up-Tear it down: protein quality control in the cardiac sarcomere.

Authors:  Monte S Willis; Jonathan C Schisler; Andrea L Portbury; Cam Patterson
Journal:  Cardiovasc Res       Date:  2008-10-29       Impact factor: 10.787

5.  Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.

Authors:  Viswanathan Rajagopalan; Mingming Zhao; Sushma Reddy; Giovanni Fajardo; Xuejun Wang; Shannamar Dewey; Aldrin V Gomes; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-31       Impact factor: 4.733

6.  Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.

Authors:  Nobutaka Nagano; Toshiyuki Yano; Yugo Fujita; Hidemichi Kouzu; Masayuki Koyama; Hiroshi Ikeda; Kenji Yasui; Atsuko Muranaka; Ryo Nishikawa; Ryo Takahashi; Naohiro Kishiue; Satoshi Yuda; Tetsuji Miura
Journal:  Heart Vessels       Date:  2019-09-26       Impact factor: 2.037

7.  A BAG3 chaperone complex maintains cardiomyocyte function during proteotoxic stress.

Authors:  Luke M Judge; Juan A Perez-Bermejo; Annie Truong; Alexandre Js Ribeiro; Jennie C Yoo; Christina L Jensen; Mohammad A Mandegar; Nathaniel Huebsch; Robyn M Kaake; Po-Lin So; Deepak Srivastava; Beth L Pruitt; Nevan J Krogan; Bruce R Conklin
Journal:  JCI Insight       Date:  2017-07-20

Review 8.  ROS signaling and ER stress in cardiovascular disease.

Authors:  Cristhiaan D Ochoa; Ru Feng Wu; Lance S Terada
Journal:  Mol Aspects Med       Date:  2018-03-22

Review 9.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

Review 10.  Molecular mechanisms underlying cardiotoxicity of novel cancer therapeutics.

Authors:  Simon Braumann; Stephan Baldus; Roman Pfister
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.